Yuji Murata — Endo Lab

article 2006

The expression of fractalkine in the endometrium during the menstrual cycle

·doi:10.1016/j.ijgo.2005.12.012

OBJECTIVE: The objective of the study was to evaluate the presence of fractalkine in the endometrium of the uterus and the change of fractalkine protein levels during menstrual cycle. METHODS: Twelve samples of endometrium of the uterus wer…

article 2005

Fractalkine in the peritoneal fluid of women with endometriosis

International Journal of Gynecology & Obstetrics ·doi:10.1016/j.ijgo.2005.06.018

OBJECTIVE: The objective of this study was to evaluate the presence of fractalkine in the ascites and the association between fractalkine levels in the ascites and endometriosis. METHODS: Peritoneal fluids and peripheral blood samples were …

article 2005

Secretory leukocyte protease inhibitor levels in cervicovaginal secretion of elderly women

·doi:10.1016/j.maturitas.2004.02.019

ObjectiveSecretory leukocyte protease inhibitor (SLPI) is a potent inhibitor of human leukocyte elastase. The aim of the present study was to examine whether there is an association between the SLPI concentration in the cervicovaginal secre…

article 2000

Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (“draw-back” therapy)

Fertility and Sterility ·doi:10.1016/s0015-0282(99)00636-6

ObjectiveTo evaluate the efficacy of half-dose GnRH agonist therapy for endometriosis.DesignProspective, longitudinal pilot study.SettingOsaka University Hospital.Patient(s)Patients with symptomatic endometriosis.Intervention(s)Fifteen pati…